Ebola-bundibugyo virus disease (ebola-BDBV)

Clinical trials for Ebola-bundibugyo virus disease (ebola-BDBV) explained in plain language.

Never miss a new study

Get alerted when new Ebola-bundibugyo virus disease (ebola-BDBV) trials appear

Sign up with your email to follow new studies for Ebola-bundibugyo virus disease (ebola-BDBV), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

Can an mRNA vaccine stop a rare ebola strain?

Vaccine Recruiting now

This early-stage trial is testing an experimental mRNA vaccine called mRNA-1469 to see if it is safe and can trigger an immune response against Ebola-Bundibugyo virus disease. Healthy adults aged 18 to 65 will receive either the vaccine or a placebo. The study focuses on safety a…

Matched conditions: EBOLA-BUNDIBUGYO VIRUS DISEASE (EBOLA-BDBV)

Phase 1 • Sponsor: ModernaTX, Inc. • Aim: Vaccine

Last updated Sep 12, 2026 00:00 UTC

Ebola-bundibugyo virus disease (ebola-BDBV)

Get alerted when new Ebola-bundibugyo virus disease (ebola-BDBV) trials appear

Can an mRNA vaccine stop a rare ebola strain?